Genetics of "late-onset" Alzheimer's disease and the immune system
Dear stanleypj - I worked on Alzheimer's for over a decade. One of my last conversations in the field was with Ruth Itzhaki!
My own specialisation was in genetics. The last couple of years have brought huge amounts of new data, mostly thanks to Prof. Julie William's (Cardiff University) and Prof. John Hardy (UCL). Of the ten or so new "risk factor" genes that have been linked to Alzheimer's disease, many have roles in inflammation and immunity. I will post a link to a recent (free) independent article on your blog.
This area is underfunded principally because almost every research dollar has been spent investigating the amyloid hypothesis. This being that accumulation in the brain of a small protein fragment (known as the amyloid-beta peptide) causes the disease.
An amyloid hypothesist would argue that the only role of the immune system in Alzheimer's is to mediate removal of amyloid from the brain. This is hypothetically what goes wrong in disease. Sadly none of the anti-amyloid drugs have proven sufficiently successful to meet regulatory approval standards.
My own personal opinion is that the long-standing focus of the field on amyloid has been a triumph of politics over science. A broader approach would definitely be beneficial at this point.
Dear stanleypj - I worked on Alzheimer's for over a decade. One of my last conversations in the field was with Ruth Itzhaki!
My own specialisation was in genetics. The last couple of years have brought huge amounts of new data, mostly thanks to Prof. Julie William's (Cardiff University) and Prof. John Hardy (UCL). Of the ten or so new "risk factor" genes that have been linked to Alzheimer's disease, many have roles in inflammation and immunity. I will post a link to a recent (free) independent article on your blog.
This area is underfunded principally because almost every research dollar has been spent investigating the amyloid hypothesis. This being that accumulation in the brain of a small protein fragment (known as the amyloid-beta peptide) causes the disease.
An amyloid hypothesist would argue that the only role of the immune system in Alzheimer's is to mediate removal of amyloid from the brain. This is hypothetically what goes wrong in disease. Sadly none of the anti-amyloid drugs have proven sufficiently successful to meet regulatory approval standards.
My own personal opinion is that the long-standing focus of the field on amyloid has been a triumph of politics over science. A broader approach would definitely be beneficial at this point.